News in the Life Sciences Industry

STOCKHOLM, May 25, 2020 /PRNewswire/ -- Q-linea AB (publ) (OMX: QLINEA), invites you to a webinar on June 5(th )at 2pm and 7pm CEST with presentations by CEO Jonas Jarvius, Research Director Mats Gullberg and Marketing & Sales Director Charlotta Göransson.

LUND, Sweden, May 25, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the ongoing EMA review of imlifidase for a potential marketing authorization in Europe is on track. A CHMP opinion is expected at the... Read more ››

STOCKHOLM, May 25, 2020 /PRNewswire/ -- Enzymatica and its partner STADA have extended its agreement for the cold spray ViruProtect(®) (ColdZyme) to cover another 19 countries in Europe. With the extended agreement STADA has provided order estimates of about SEK 20 million for 2020. The... Read more ››

STOCKHOLM, May 22, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces a successful completion of enrollment in the pivotal phase 3 study OCEAN for the treatment of relapsed refractory multiple myeloma. The study includes 450 patients from more than 100 hospitals... Read more ››

STOCKHOLM, May 21, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated... Read more ››

STOCKHOLM, May 20, 2020 /PRNewswire/ -- Today, 20 May 2020, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions were passed with the required majority.

TAIPEI, Taiwan, May 20, 2020 /PRNewswire/ -- OBI Pharma, Inc. (TPEx: 4174), a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and SSEA-4) and chemotherapeutics targeting AKR1C3, today announced that data highlighting the ongoing clinical... Read more ››

STOCKHOLM, May 20, 2020 /PRNewswire/ -- OrtoWay AB, makers of the OrtoWell(®) Distractor - the world's first hydraulically powered device for spinal surgery - today announces new tool design improvements extending the clinical usage. It has also formed a new subsidiary and established manufacturing... Read more ››

LUND, Sweden, May 20, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's novel IgG-degrading enzyme, imlifidase, will be highlighted in three presentations including a late breaking poster presentation... Read more ››

LUND, Sweden, May 20, 2020 /PRNewswire/ -- Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, summons to Annual General Meeting on Tuesday June 23, 2020 at 15:00 CEST at the Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund, Sweden. Registration will begin... Read more ››

STOCKHOLM, May 20, 2020 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that Tara Heitner PhD MBA has been appointed new CEO for the company by Board of Directors.

UPPSALA, Sweden, May 19, 2020 /PRNewswire/ -- Today on 19 May 2020, Orexo AB (publ) held an extraordinary general meeting. The extraordinary general meeting passed the following resolutions.

STOCKHOLM, May 19, 2020 /PRNewswire/ -- IRRAS AB (publ) ("IRRAS", or the "Company") announces that Nasdaq Stockholm's listing committee has approved the Company for listing on Nasdaq Stockholm's main list. In connection with the list change from Nasdaq First North Premier Growth Market to... Read more ››